Item request has been placed!
×
Item request cannot be made.
×

Processing Request
Virus Shedding and Diarrhea: A Review of Human Norovirus Genogroup II Infection in Gnotobiotic Pigs.
Item request has been placed!
×
Item request cannot be made.
×

Processing Request
- المؤلفون: Nyblade C;Nyblade C; Yuan L; Yuan L
- المصدر:
Viruses [Viruses] 2024 Sep 07; Vol. 16 (9). Date of Electronic Publication: 2024 Sep 07.
- نوع النشر :
Journal Article; Review
- اللغة:
English
- معلومة اضافية
- المصدر:
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE
- بيانات النشر:
Original Publication: Basel, Switzerland : MDPI
- الموضوع:
- نبذة مختصرة :
For nearly twenty years, gnotobiotic (Gn) pigs have been used as a model of human norovirus (HuNoV) infection and disease. Unique in their ability to develop diarrhea and shed virus post oral challenge, Gn pigs have since been used to evaluate the infectivity of several genogroup II HuNoV strains. Nearly all major pandemic GII.4 variants have been tested in Gn pigs, with varying rates of infectivity. Some induce an asymptomatic state despite being shed in large quantities in stool, and others induce high incidence of both diarrhea and virus shedding. Non-GII.4 strains, including GII.12 and GII.6, have also been evaluated in Gn pigs. Again, rates of diarrhea and virus shedding tend to vary between studies. Several factors may influence these findings, including age, dosage, biological host factors, or bacterial presence. The impact of these factors is nuanced and requires further evaluation to elucidate the exact mechanisms behind increases or decreases in infection rates. Regardless, the value of Gn pig models in HuNoV research cannot be understated, and the model will surely continue to contribute to the field in years to come.
- References:
J Virol. 2014 Sep 1;88(17):9728-43. (PMID: 24920797)
Science. 2016 Aug 26;353(6302):933-6. (PMID: 27540007)
Sci Rep. 2016 Apr 27;6:25222. (PMID: 27118081)
Viruses. 2019 Jul 11;11(7):. (PMID: 31336765)
J Infect Dis. 2014 Apr 1;209(7):1016-22. (PMID: 24253285)
PLoS One. 2016 Apr 26;11(4):e0151219. (PMID: 27115736)
Virus Res. 2023 Oct 15;336:199219. (PMID: 37683935)
Nat Rev Microbiol. 2016 Apr;14(4):197-204. (PMID: 26853118)
Science. 2016 Sep 23;353(6306):1387-1393. (PMID: 27562956)
J Microbiol Biotechnol. 2018 Dec 28;28(12):2133-2140. (PMID: 30661347)
Gut Microbes. 2021 Jan-Dec;13(1):1979876. (PMID: 34586017)
Lancet. 2018 Jul 14;392(10142):175-186. (PMID: 30025810)
Clin Microbiol Rev. 2015 Jan;28(1):134-64. (PMID: 25567225)
J Gen Virol. 2019 Nov;100(11):1530-1540. (PMID: 31596195)
J Infect Dis. 2012 Nov;206(9):1386-93. (PMID: 22927452)
Viruses. 2021 Aug 04;13(8):. (PMID: 34452406)
J Infect Dis. 2024 Feb 21;:. (PMID: 38382087)
Sci Rep. 2016 Apr 26;6:25017. (PMID: 27113278)
Nature. 2022 Jul;607(7918):345-350. (PMID: 35768512)
Viruses. 2021 Jan 11;13(1):. (PMID: 33440894)
J Virol. 2007 Apr;81(7):3535-44. (PMID: 17215284)
J Med Virol. 2023 Jan;95(1):e28321. (PMID: 36397269)
PLoS One. 2018 Feb 13;13(2):e0178157. (PMID: 29438433)
J Infect Dis. 2000 May;181 Suppl 2:S295-302. (PMID: 10804141)
Vaccine. 2007 Dec 5;25(50):8448-59. (PMID: 18022293)
J Virol. 2007 Sep;81(17):9183-92. (PMID: 17581999)
mBio. 2013 Jul 16;4(4):. (PMID: 23860770)
Clin Microbiol Infect. 2014 Aug;20(8):717-23. (PMID: 25040790)
Science. 2014 Nov 7;346(6210):755-9. (PMID: 25378626)
Viruses. 2022 Sep 16;14(9):. (PMID: 36146859)
Viruses. 2020 Aug 28;12(9):. (PMID: 32872283)
J Gen Virol. 2013 Sep;94(Pt 9):2005-2016. (PMID: 23804568)
PLoS One. 2012;7(7):e41619. (PMID: 22911825)
Viruses. 2021 Jan 30;13(2):. (PMID: 33573340)
Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):. (PMID: 33836574)
Vaccines (Basel). 2024 May 29;12(6):. (PMID: 38932319)
J Med Virol. 1978;2(2):89-96. (PMID: 97364)
Viruses. 2019 Mar 02;11(3):. (PMID: 30832363)
Pathogens. 2021 Jul 01;10(7):. (PMID: 34357979)
Viruses. 2019 Feb 12;11(2):. (PMID: 30759780)
J Infect Dis. 2022 Jan 5;225(1):105-115. (PMID: 34129046)
Virus Res. 2019 Jul 2;267:21-25. (PMID: 31054932)
J Virol. 2006 Nov;80(21):10372-81. (PMID: 17041218)
Nat Microbiol. 2024 Mar;9(3):776-786. (PMID: 38321182)
Viruses. 2019 Aug 17;11(8):. (PMID: 31426458)
J Med Virol. 2022 Nov;94(11):5149-5162. (PMID: 35882942)
J Virol. 2006 Jun;80(11):5104-12. (PMID: 16698991)
mSphere. 2021 Jan 27;6(1):. (PMID: 33504663)
J Virol. 2008 Feb;82(4):1777-86. (PMID: 18045944)
Nat Protoc. 2015 Dec;10(12):1939-47. (PMID: 26513671)
- Grant Information:
R01AI148357 United States AI NIAID NIH HHS; R41AI172485 United States AI NIAID NIH HHS
- Contributed Indexing:
Keywords: gnotobiotic pigs; human norovirus
- الموضوع:
Date Created: 20240928 Date Completed: 20240928 Latest Revision: 20240930
- الموضوع:
20250114
- الرقم المعرف:
PMC11437449
- الرقم المعرف:
10.3390/v16091432
- الرقم المعرف:
39339908
No Comments.